MiroBio
Oxford · Founded 2019
About MiroBio
MiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated. These insights have enabled MiroBio to create antibodies that can leverage natural signalling mechanisms to restore immune system balance and control.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $130.2M
- Funding stage: M&A
- Last round: Series B (Jun 2022)
- Website: http://www.mirobio.com/
- Phone: 01865 618817
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mirobio-5579 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.